Literature DB >> 30948166

Detection of tuberculosis laboratory cross-contamination using whole-genome sequencing.

Jie Wu1, Chongguang Yang2, Liping Lu3, Wanqin Dai4.   

Abstract

OBJECTIVE: Detection of tuberculosis laboratory cross-contamination using whole-genome sequencing.
METHODS: A total of 22 M. tuberculosis strains with high genotypic homology from one hospital were collected during the drug resistance surveillance. Genome sequencing and epidemiological investigation were conducted to determine the occurrence of cross-contamination.
RESULTS: The pair wise comparison between the genomes in each cluster indicated that 15 (71.4%) of 21 strains with available genomic data had no SNP differences with at least one other strain within the same cluster. The analysis of the specimen collection time found that, among the 16 strains collected on the same day, 14 (87.5%) of them had no SNP differences with one another strain; meanwhile, among the strains within the same cluster whose SNP distance was 0, 93.3% (14/15) of them had the same collection time, suggesting that these findings were most likely caused by cross contamination.
CONCLUSION: A high proportion of M. tuberculosis strains with genotypic homology from the single institute that shared the same process time period was most likely caused by the cross contamination. Whole genome sequencing analysis can help to determine the occurrence of cross contamination.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Cross-contamination; Mycobacterium tuberculosis; Whole-genome sequencing

Mesh:

Year:  2019        PMID: 30948166      PMCID: PMC6613641          DOI: 10.1016/j.tube.2018.10.012

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  1 in total

1.  Cross-Contamination versus Outbreak: Pre-XDR Mycobacterial Strains Confirmed by Whole-Genome Sequencing.

Authors:  Jee Youn Oh; Kyung Ho Park; Jisoon Lee; Donghyeok Kim; Kwang Hyuk Seok; In-Hwan Oh; Seung Heon Lee
Journal:  Antibiotics (Basel)       Date:  2021-03-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.